Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Adeona, TG United enter commercial-scale manufacturing agreement for reaZin

Adeona Pharmaceuticals, Inc., a developer of innovative medicines for serious central nervous system diseases, announced today that it has executed an agreement with TG United, Inc. of Brooksville, Florida, to provide commercial-scale manufacturing capabilities for reaZin. Adeona is developing reaZin, its product candidate for the dietary management of Alzheimer's disease and mild cognitive impairment, as a prescription medical food.

20 Apr 2011

Chembio initiates FDA Modular PMA process for DPP HIV 1/2 Screening Assay

Chembio Diagnostics, Inc., which develops, manufactures, markets and licenses point-of-care diagnostic tests, reported it recently filed the first module of its Pre-Marketing Approval (PMA) application to the United States Food & Drug Administration for its DPP® HIV 1/2 Screening Assay.

19 Apr 2011

Johnson & Johnson reports net sales of $16.2 billion for first quarter 2011

Johnson & Johnson today announced sales of $16.2 billion for the first quarter of 2011, an increase of 3.5% as compared to the first quarter of 2010.

19 Apr 2011

Cumberland acquires Vanderbilt's ifetroban rights

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company focused on hospital acute care and gastroenterology markets, today announced that it has entered into an agreement to acquire the rights to ifetroban, a new Phase II development product.

19 Apr 2011

Seattle enters second ADC research collaboration agreement with Genmab

Genmab A/S and Seattle Genetics, Inc. announced today that the companies have entered into a second antibody-drug conjugate research collaboration agreement.

19 Apr 2011

Single antibody injection limits tissue and organ destruction after ischaemic events

Medical researchers today held out promise that a simple injection is being developed to limit the devastating consequences of heart attacks and strokes.

19 Apr 2011

Obama to rally support for his deficit-reduction plan

President Barack Obama will take his message on the road with a "series of campaign-style stops" in an effort to block a Republican deficit-reduction blueprint that would dramatically change Medicare and other social programs.

18 Apr 2011

First Edition: April 18, 2011

Today's headlines include a report about President Barack Obama's plan to rally support for his deficit reduction plan and to block GOP changes to Medicare and other social programs.

18 Apr 2011

Tibet Pharmaceuticals' updated online Investor Fact Sheet is now available in China

Tibet Pharmaceuticals, Inc., an emerging specialty pharmaceutical company engaged in the development, manufacturing and marketing of traditional Tibetan medicine in China, announces the availability of an updated online Investor Fact Sheet.

18 Apr 2011

Nuvo Research to acquire ZARS Pharma

Nuvo Research Inc., a pharmaceutical company dedicated to building a portfolio of products primarily for the treatment of pain, today announced that it has entered into an agreement to acquire ZARS Pharma, Inc., a specialty pharmaceutical company based in Salt Lake City, Utah.

18 Apr 2011

Pharmatek receives U.S. DEA approval for Schedule I-V controlled substance analysis

Pharmatek Laboratories, Inc., a premier contract development and manufacturing organization supporting the pharmaceutical industry, announced that it has been approved by the United States Drug Enforcement Agency for the analysis of Schedules I through V controlled substances, complementing its existing license to develop and manufacture drug products containing Schedules IV and V controlled substances.

18 Apr 2011

Thermo Fisher Scientific introduces wireless sample monitoring solution

Thermo Fisher Scientific Inc., the world leader in serving science, today introduced its new Thermo Scientific Smart-Vue wireless monitoring solution. Smart-Vue™ protects precious samples by monitoring key laboratory parameters including temperature, CO2 concentration, humidity and differential pressure. It can be installed by the user on most laboratory equipment, including ultra-low temperature freezers, laboratory refrigerators, CO2 incubators and clean rooms.

From Thermo Fisher Scientific Inc. 16 Apr 2011

EMA recommends lifting of suspension of marketing authorization for Octapharma's octagam

The Committee for Medicinal Products for Human Use (CHMP) of the The European Medicines Agency (EMA) has recommended today to lift the EU-wide suspension of the marketing authorizations of both octagam® and octagam®10% which has been in place since September 2010, subject to certain conditions.

15 Apr 2011

Organic pollutants in flame retardents cause molecular changes in reproductive organs

Polybrominated diphenyl ethers (PBDEs) are chemicals that have been widely used as flame retardants and are now classified as persistent organic pollutants. Health concerns in humans have arisen based primarily on studies with laboratory animals exposed to high levels of PBDEs. Three commercial mixtures of PBDEs have been manufactured in or imported into the United States which include penta-, octa-, and deca-brominated diphenyl ethers (BDEs).

15 Apr 2011

Quest PharmaTech, Hemispherx Biopharma enter clinical development arrangement

Quest PharmaTech Inc., a pharmaceutical company developing and commercializing products for the treatment of cancer, today announced a clinical development arrangement with U.S. based Hemispherx Biopharma Inc. to evaluate the clinical utility of combining Quest's antibody immunotherapy technology with Hemispherx's immune activator in a thirty patient clinical trial.

15 Apr 2011

Study: Simple illusion can reduce arthritic pain

A serendipitous discovery by academics at The University of Nottingham has shown that a simple illusion can significantly reduce — and in some cases even temporarily eradicate — arthritic pain in the hand.

15 Apr 2011

Novartis, Duke sign deal to develop pandemic flu vaccine

The Duke Human Vaccine Institute today announced a collaboration and strategic agreement with Novartis Vaccines and Diagnostics to enable the rapid development of a vaccine and accelerate preparedness in case of a pandemic virus threat such as pandemic influenza.

15 Apr 2011

Obama’s next target - medical error reduction for patient safety

Finally serious efforts are being made to ensure patient safety. The Obama administration announced this Tuesday an aggressive approach called ‘The 'Partnership for Patients Program’ to reduce medical errors, partnering with private insurers, business leaders, hospitals and patient advocates to tackle a problem that kills thousands of Americans every year.

12 Apr 2011

Nano Terra announces acquisition of Surface Logix

Nano Terra, Inc., a leading surface engineering and nanotechnology co-development company, today announced it is acquiring Surface Logix, Inc., a drug development company founded by renowned Harvard scientist Professor George Whitesides. Surface Logix has made significant breakthroughs in enhancing the molecular functionality of pharmaceuticals and advancing several drug candidates.

12 Apr 2011

PAREXEL's QbD approaches can help pharma companies maximize product quality, safety

PAREXEL International Corporation, a leading global biopharmaceutical services provider, and the Parenteral Drug Association today announced the publication of Quality by Design: Putting Theory into Practice, written to help companies maximize product quality and safety. As increasing regulatory pressure is being placed on biopharmaceutical companies to be accountable for Quality Systems, the book serves as a definitive source on the interpretation and implementation of Quality by Design approaches.

From Parexel 11 Apr 2011

Manufacturing News and Research

Further Reading

Adeona, TG United enter commercial-scale manufacturing agreement for reaZin

Chembio initiates FDA Modular PMA process for DPP HIV 1/2 Screening Assay

Johnson & Johnson reports net sales of $16.2 billion for first quarter 2011

Cumberland acquires Vanderbilt's ifetroban rights

Seattle enters second ADC research collaboration agreement with Genmab

Single antibody injection limits tissue and organ destruction after ischaemic events

Obama to rally support for his deficit-reduction plan

First Edition: April 18, 2011

Tibet Pharmaceuticals' updated online Investor Fact Sheet is now available in China

Nuvo Research to acquire ZARS Pharma

Pharmatek receives U.S. DEA approval for Schedule I-V controlled substance analysis

Thermo Fisher Scientific introduces wireless sample monitoring solution

EMA recommends lifting of suspension of marketing authorization for Octapharma's octagam

Organic pollutants in flame retardents cause molecular changes in reproductive organs

Quest PharmaTech, Hemispherx Biopharma enter clinical development arrangement

Study: Simple illusion can reduce arthritic pain

Novartis, Duke sign deal to develop pandemic flu vaccine

Obama’s next target - medical error reduction for patient safety

Nano Terra announces acquisition of Surface Logix

PAREXEL's QbD approaches can help pharma companies maximize product quality, safety

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest Life Science News